The targeting of FOXD1 might be a good strategy to enhance the radiosensitivity of oral cancer cells via downregulating G3BP2-related pathways and upregulating the TXNIP-associated cellular functions. Here, TXNIP is linked to lip and oral cavity carcinoma.